Clinical Trial Update: Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 study comparing two doses of AZD9567 with prednisolone in adults with Type 2 diabetes assessed effects on glucose homeostasis; results have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD9567 (AZD9567)
• Prednisolone (Prednisolone)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2024-07-18